정신 건강 검진 시장 예측(-2030년) : 제품, 질병 유형, 검진 방법, 연령대, 용도, 최종 사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Mental Health Screening Market is accounted for $950.00 million in 2023 and is expected to reach $2,406.50 million by 2030 growing at a CAGR of 14.2% during the forecast period. Mental health screening is a process used to assess an individual's psychological well-being and detect potential mental health concerns. It involves the administration of standardized tools or questionnaires to evaluate various aspects of mental health, such as mood, anxiety, and cognitive functioning. These screenings can be conducted by healthcare professionals, including psychologists, psychiatrists, or primary care physicians, as well as through self-assessment tools available online or in print.

According to the World Health Organization (WHO), mental health conditions account for 16% of the global burden of disease and injury in people aged 10-19 years.

Market Dynamics:

Driver:

Rising prevalence of mental disorders

The increasing prevalence of mental disorders has become a significant driver for the expansion of the mental health screening market. As awareness and understanding of mental health grow, more individuals are seeking diagnosis and treatment. This surge in demand necessitates efficient screening tools to identify mental health issues early on. Consequently, healthcare providers are investing in innovative screening technologies and platforms to meet this demand. Moreover, societal efforts to reduce stigma surrounding mental health have encouraged more people to seek help, further driving the need for accessible screening services.

Restraint:

Stigma and perception

Stigma surrounding mental health issues often deters individuals from seeking screening, fearing judgment or discrimination. This societal stigma can perpetuate misconceptions and hinder open discussions about mental well-being. Moreover, perceptions of mental health screening as unnecessary or intrusive can restrain market growth, as potential users may perceive it as an invasion of privacy or an acknowledgment of weakness. Overcoming these barriers requires comprehensive education campaigns to destigmatize mental health discussions and emphasize the importance of early detection through screening.

Opportunity:

Personalized screening solutions

The Personalized Screening Solutions opportunity lies in its tailored approach to assessing individuals' mental well-being. By offering customizable screening tools, it addresses the diverse needs and nuances of each person's mental health profile. This approach can lead to more accurate assessments, early detection of issues, and personalized intervention strategies. Leveraging advanced technology like AI and machine learning, personalized screening solutions can offer efficient, scalable, and user-friendly screening solutions. Furthermore, by incorporating elements of personalization and customization, it enhances user engagement and compliance, thereby improving overall mental health outcomes. In a rapidly evolving mental health landscape, this innovative approach presents a promising avenue for addressing the growing demand for accessible and effective screening methods.

Threat:

Misdiagnosis

The misdiagnosis threat is the risk of inaccurately identifying or labeling individuals with mental health conditions. This can occur due to various factors, such as subjective interpretation of symptoms, limited assessment tools, or insufficient training of screeners. Misdiagnosis can lead to inappropriate treatments, stigma, and the exacerbation of symptoms. Moreover, it may deter individuals from seeking help or receiving proper care. To mitigate this threat, there's a need for standardized screening protocols, ongoing professional development for screeners, and increased awareness about the complexities of mental health diagnoses.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the mental health screening market, leading to both challenges and opportunities. On one hand, the increased stress, isolation, and uncertainty caused by the pandemic have amplified the demand for mental health services, including screenings, as people seek support for their psychological well-being. This surge in demand has led to a greater recognition of the importance of mental health screening and early intervention. Additionally, the shift to remote work and virtual healthcare has prompted the development of digital mental health screening tools and telehealth platforms, presenting new avenues for reaching individuals in need of mental health support.

The remote mental health platforms segment is expected to be the largest during the forecast period

The growth of remote mental health platforms within the mental health screening market is fueled by several factors. Firstly, the increasing awareness and acceptance of mental health issues have led to a higher demand for accessible and convenient screening options. These platforms offer individuals the ability to assess their mental health from the comfort of their own homes, removing barriers such as stigma or geographical constraints. Moreover, advancements in technology, particularly in telemedicine and digital health, have made remote mental health screening more feasible and user-friendly. With the proliferation of smartphones and internet connectivity, people have greater access to these platforms, further driving their growth.

The software segment is expected to have the highest CAGR during the forecast period

The software segment within the mental health screening market has experienced significant growth due advancements in technology that enabled the development of sophisticated screening tools that can efficiently assess various mental health conditions. These software solutions often offer user-friendly interfaces, allowing for easy access and utilization by both healthcare professionals and patients. Moreover, the increasing awareness and destigmatization surrounding mental health issues have spurred greater demand for screening services, leading to a higher adoption of software-based solutions. Furthermore, the scalability and cost-effectiveness of software solutions make them attractive options for healthcare providers and organizations seeking to streamline their mental health screening processes.

Region with largest share:

In recent years, North America has witnessed a notable expansion in the mental health screening market. This growth can be attributed to increasing awareness and destigmatization efforts surrounding mental health that prompted more individuals to seek screening services. Government initiatives and healthcare reforms emphasizing mental health care have spurred investment in screening infrastructure. Furthermore, the COVID-19 pandemic has exacerbated mental health concerns, leading to a greater focus on early detection and intervention. Lastly, collaborations between healthcare providers, tech companies, and research institutions have fostered innovation and widened the market's reach.

Region with highest CAGR:

The Asia-Pacific region has witnessed significant growth due to several factors. Increasing awareness about mental health issues, coupled with rising acceptance has fuelled the demand for screening services. Governments and healthcare organizations in countries like China, India, and Australia are investing more in mental health initiatives, driving market expansion. Additionally, the region's large population base, particularly in urban areas, presents a vast market for mental health screening services. Technological advancements, such as telepsychiatry and digital screening tools, are also facilitating easier access to mental health services, further propelling market growth in the Asia-Pacific region.

Key players in the market

Some of the key players in Mental Health Screening market include Aiberry, Apple inc., Canary speech, inc., Cognitive health solutions, Ellipsis health, inc., Google Fitbit, Headspace health, Kintsugi mindful wellness, inc., Koninklijke philips n.v., Mindwise Innovations, Modern life, inc., Quartet health, inc., Resmed inc., Sonde health, inc., Thymia limited and Total Brain.

Key Developments:

In March 2024, ResMed announced that it launched the AirFit F40 ultra-compact, full-face mask for sleep apnea. San Diego-based ResMed designed AirFit F40 to offer the comfort of smaller masks without sacrificing performance. This could, in turn, help with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment.

In November 2023, Ellipsis Health announced its sponsorship of the Asia-Pacific Economic Cooperation (APEC) Summit, highlighting its commitment to improving mental healthcare in San Francisco and beyond and raising awareness for access to treatment for all communities.

Products Covered:

• Continuous Monitoring Wearable Devices
• Remote Mental Health Platforms
• Telehealth & Virtual Care Solutions
• Al-based Screening Tools
• Self-screening mHealth Apps
• Other Products

Disease Types Covered:

• Behavioral Disorders
• Psychiatric Disorders
• Cognitive Impairment
• Physiological Disorders
• Other Disease Types

Screening Methods Covered:

• Observation-based Assessments
• Biomarker Testing
• Clinical Interviews
• Self-reported Questionnaires & Surveys
• Other Screening Methods

Age Groups Covered:

• Age 0-18 Years
• Age 19-60
• Age 60 and above

Applications Covered:

• Services
• Software
• Mobile
• Wearables
• Other Applications

End Users Covered:

• Educational Institutions
• Workplace/Corporate Programs
• Clinical Settings
• Online Platforms
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Mental Health Screening Market, By Product

• 5.1 Introduction
• 5.2 Continuous Monitoring Wearable Devices
• 5.3 Remote Mental Health Platforms
• 5.4 Telehealth & Virtual Care Solutions
• 5.5 Al-based Screening Tools
• 5.6 Self-screening mHealth Apps
• 5.7 Other Products

6 Global Mental Health Screening Market, By Disease Type

• 6.1 Introduction
• 6.2 Behavioral Disorders
  • 6.2.1 Self-Harm
  • 6.2.2 Social Withdrawal
  • 6.2.3 Sleep Disorder
  • 6.2.4 Hyperactivity
  • 6.2.5 Aggression
  • 6.2.6 Other Behavioral Disorders
• 6.3 Psychiatric Disorders
  • 6.3.1 Psychotic Disorder
  • 6.3.2 Schizophrenia
  • 6.3.3 Dissociative Disorder
  • 6.3.4 Obsessive Compulsive Disorder
  • 6.3.5 Attention Deficit Hyperactivity Disorder (ADHD)
  • 6.3.6 Other Psychiatric Disorders
• 6.4 Cognitive Impairment
  • 6.4.1 Dementia
  • 6.4.2 Alzheimer's Disease
  • 6.4.3 Other Cognitive Disorders
• 6.5 Physiological Disorders
  • 6.5.1 Anxiety
  • 6.5.2 Bipolar Disorder
  • 6.5.3 Depression
  • 6.5.4 Eating Disorder
  • 6.5.5 Post-Traumatic Stress Disorder (PTSD)
  • 6.5.6 Substance Abuse
  • 6.5.7 Other Physiological Disorders
• 6.6 Other Disease Types

7 Global Mental Health Screening Market, By Screening Method

• 7.1 Introduction
• 7.2 Observation-based Assessments
• 7.3 Biomarker Testing
• 7.4 Clinical Interviews
  • 7.4.1 Diagnostic Interview for Psychological Distress (DIPD)
  • 7.4.2 Mini International Neuropsychiatric Interview (MINI)
  • 7.4.3 Structured Clinical Interview for DSM (SCID)
  • 7.4.4 Other Clinical Interviews
• 7.5 Self-reported Questionnaires & Surveys
  • 7.5.1 Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
  • 7.5.2 Patient Health Questionnaire-12 (PHQ-12)
  • 7.5.3 Hamilton Anxiety Rating Scale (HAM-A)
  • 7.5.4 Generalized Anxiety Disorder-7 (GAD-7)
  • 7.5.5 Beck Depression Inventory (BDI)
  • 7.5.6 Other Self-reported Questionnaires & Surveys
• 7.6 Other Screening Methods

8 Global Mental Health Screening Market, By Age Group

• 8.1 Introduction
• 8.2 Age 0-18 Years
• 8.3 Age 19-60
• 8.4 Age 60 and above

9 Global Mental Health Screening Market, By Application

• 9.1 Introduction
• 9.2 Services
• 9.3 Software
• 9.4 Mobile
• 9.5 Wearables
• 9.6 Other Applications

10 Global Mental Health Screening Market, By End User

• 10.1 Introduction
• 10.2 Educational Institutions
• 10.3 Workplace/Corporate Programs
• 10.4 Clinical Settings
• 10.5 Online Platforms
• 10.6 Other End Users

11 Global Mental Health Screening Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Aiberry
• 13.2 Apple inc.
• 13.3 Canary speech, inc.
• 13.4 Cognitive health solutions
• 13.5 Ellipsis health, inc.
• 13.6 Google Fitbit
• 13.7 Headspace health
• 13.8 Kintsugi mindful wellness, inc.
• 13.9 Koninklijke philips n.v.
• 13.10 Mindwise Innovations
• 13.11 Modern life, inc.
• 13.12 Quartet health, inc.
• 13.13 Resmed inc.
• 13.14 Sonde health, inc.
• 13.15 Thymia limited
• 13.16 Total Brain